Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Physical Growth”

Showing 20 of 0 results

Not applicableStudy completedNCT01504802
What this trial is testing

Pharmacodynamics of CNP During Growth Hormone Treatment

Who this might be right for
Pituitary DwarfismIdiopathic Short Stature
Nemours Children's Clinic 22
Not applicableStudy completedNCT06642337
What this trial is testing

Nutritional Educational Program On Therapy in Iron Deficiency Anemia

Who this might be right for
Iron Deficiency Anemia (IDA)Nutrition DisordersGrowth Retardation
Hawler Medical University 180
Not applicableStudy completedNCT00187577
What this trial is testing

Efficacy Study of Latanoprost and Bimatoprost Solutions in Promoting Eyelash Growth in Patients With Alopecia Areata

Who this might be right for
Alopecia Areata
University of California, San Francisco 14
Testing effectiveness (Phase 2)Study completedNCT01221077
What this trial is testing

Study of Erlotinib (Tarceva®) in Combination With OSI-906 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) With Activating Mutations of the Epidermal Growth Factor Receptor (EGFR) Gene

Who this might be right for
NSCLCNon Small Cell Lung Cancer
Astellas Pharma Inc 88
Not applicableStudy completedNCT01439061
What this trial is testing

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Italy

Who this might be right for
Growth Disorders
Merck KGaA, Darmstadt, Germany 220
Large-scale testing (Phase 3)Study completedNCT00524849
What this trial is testing

Zometa and Circulating Vascular Endothelial Growth Factor (VEGF) in Breast Cancer Patients With Bone Metastasis

Who this might be right for
Metastatic Breast CancerBone Metastases
Fudan University 60
Testing effectiveness (Phase 2)Looking for participantsNCT07049055
What this trial is testing

A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer, MetastaticPDAC - Pancreatic Ductal Adenocarcinoma
Engeneic Pty Limited 144
Not applicableStudy completedNCT06463626
What this trial is testing

Real-life Treatment Patterns With Cyclin-dependent Kinase Inhibitors in Advanced Breast Cancer in Portugal - REVEAL Study

Who this might be right for
Hormone-receptor-positive Breast CancerHuman Epidermal Growth Factor 2 Negative Carcinoma of Breast
Novartis 121
Not applicableStudy completedNCT01028638
What this trial is testing

Vascular Endothelial Growth Factor (VEGF) Imaging Before and During Everolimus Treatment for Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
University Medical Center Groningen 13
Not applicableStudy completedNCT00843349
What this trial is testing

Fibroblast Growth Factor-23 (FGF23) Reduction in Predialysis Chronic Kidney Disease (CKD)

Who this might be right for
Kidney Disease
Myles Wolf 43
Not applicableUnknownNCT04736615
What this trial is testing

SAFEWATER Health & Behaviour Impact Field Trials; Mexico

Who this might be right for
Water-Related Diseases
University of Ulster 200
Not applicableUnknownNCT01660308
What this trial is testing

Observing the Changes of Fibroblast Growth Factor 23 in Patients of Tumor Induced Osteomalacia

Who this might be right for
Hypophosphatemia
National Taiwan University Hospital 40
Early research (Phase 1)Study completedNCT07795138
What this trial is testing

Comparative Effect of Conventional and 3D-printed Twin Block Appliances on Soft Tissue Changes

Who this might be right for
Class II Malocclusion
Al-Azhar University 20
Large-scale testing (Phase 3)UnknownNCT04047758
What this trial is testing

Palbociclib Combined With an Aromatase Inhibitor in Breast Cancer

Who this might be right for
Breast Cancer
Shengjing Hospital 420
Not applicableStudy completedNCT01263457
What this trial is testing

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in the UK

Who this might be right for
Growth Disorders
Merck KGaA, Darmstadt, Germany 191
Early research (Phase 1)WithdrawnNCT05905341
What this trial is testing

Study of PF-07224826, as a Single Agent or in Combination With Endocrine Therapy in Participants With Breast Cancer and Other Advanced Solid Tumors.

Who this might be right for
Breast CancerOvarian CancerLiposarcoma+3 more
Pfizer
Not applicableNot Yet RecruitingNCT04484051
What this trial is testing

Growth Hormone Study in Adults With Prader-Willi Syndrome

Who this might be right for
Prader-Willi Syndrome
Erasmus Medical Center 25
Testing effectiveness (Phase 2)Study completedNCT04677595
What this trial is testing

Study of Capmatinib in Chinese Adult Patients With Advanced Non-small Cell Lung Cancer Harboring MET Exon 14 Skipping Mutation

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
Novartis Pharmaceuticals 36
Not applicableStudy completedNCT00565357
What this trial is testing

Silicone Earplugs for VLBW Newborns in Intensive Care

Who this might be right for
Postnatal Growth
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 34
Large-scale testing (Phase 3)Study completedNCT02019277
What this trial is testing

Pertuzumab and Trastuzumab Subcutaneous (SC) Treatment in Combination With a Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 50
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation